Sign in

CIK 0001824893

  • Non-accelerated filer
  • Smaller reporting company

Surrozen, Inc./DE

Sign in to watch
Ticker
SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
301374889
Phone
+1 650-475-2820
Business address
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Consonance-HFW Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy 10% owner bought 18,856 shares at an average $23.59 ($444,844)
  5. 4 Open-market buy 10% owner bought 9,357 shares at an average $21.65 ($202,534)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy 10% owner bought 32,507 shares at an average $19.74 ($641,597)
  9. 4 Open-market buy Director bought 32,507 shares at an average $19.74 ($641,597)
  10. 4 Open-market buy Director bought 17,993 shares at an average $19.86 ($357,353)
  11. 4 Open-market buy 10% owner bought 17,993 shares at an average $19.86 ($357,353)
  12. 4 Open-market buy 10% owner bought 15,100 shares at $19.89 ($300,297)
  13. 4 Open-market buy Director bought 15,100 shares at $19.89 ($300,297)
  14. 4 Open-market sale Exec. Vice President, Research sold 1,118 shares at $19.87 ($22,209)
  15. 4 Open-market sale Chief Operating Officer sold 1,566 shares at $19.87 ($31,109)
  16. 4 Grant or award Exec. Vice President, Research acquired 1,666 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 1,666 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 1,553 shares (grant or award)
  19. 4 Open-market buy Director bought 36,150 shares at an average $19.22 ($694,850)
  20. 4 Open-market buy 10% owner bought 36,150 shares at an average $19.22 ($694,850)

Page 2 of 10 · 189 filings